1-4 of 4
Barath Shreeder
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1484: SCD-1 blockade sensitizes triple negative breast cancer to immune checkpoint inhibition

Free
Sneha Vivekanandhan, Justyna Trynda, Laura A. Marlow, Barath shreeder, James L. Miller, Adam M. Kase, Winston Tan, Keith L. Knutson, John A. Copland
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1484.
https://doi.org/10.1158/1538-7445.AM2021-1484
Published: 01 July 2021
View articletitled, Abstract 1484: SCD-1 blockade sensitizes triple negative breast cancer to immune checkpoint inhibition
Journal Articles

IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer

Free
Purushottam Lamichhane, Lavakumar Karyampudi, Barath Shreeder, James Krempski, Deborah Bahr, Joshua Daum, Kimberly R. Kalli, Ellen L. Goode, Matthew S. Block, Martin J. Cannon, Keith L. Knutson
Journal: Cancer Research
Cancer Res (2017) 77 (23): 6667–6678.
https://doi.org/10.1158/0008-5472.CAN-17-0740
Published: 30 November 2017
View articletitled, IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer
Open the PDF for IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain

Free
Keith L. Knutson, Raphael Clynes, Barath Shreeder, Patrick Yeramian, Kathleen P. Kemp, Karla Ballman, Kathleen S. Tenner, Courtney L. Erskine, Nadine Norton, Donald Northfelt, Winston Tan, Carmen Calfa, Mark Pegram, Elizabeth A. Mittendorf, Edith A. Perez
Journal: Cancer Research
Cancer Res (2016) 76 (13): 3702–3710.
https://doi.org/10.1158/0008-5472.CAN-15-3091
Published: 30 June 2016
View articletitled, Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain
Open the PDF for Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain in another window
Includes: Supplementary data
Journal Articles

Accumulation of Memory Precursor CD8 T Cells in Regressing Tumors following Combination Therapy with Vaccine and Anti-PD-1 Antibody

Free
Lavakumar Karyampudi, Purushottam Lamichhane, Adam D. Scheid, Kimberly R. Kalli, Barath Shreeder, James W. Krempski, Marshall D. Behrens, Keith L. Knutson
Journal: Cancer Research
Cancer Res (2014) 74 (11): 2974–2985.
https://doi.org/10.1158/0008-5472.CAN-13-2564
Published: 29 May 2014
View articletitled, Accumulation of Memory Precursor CD8 T Cells in Regressing Tumors following Combination Therapy with Vaccine and Anti-PD-1 Antibody
Open the PDF for Accumulation of Memory Precursor CD8 T Cells in Regressing Tumors following Combination Therapy with Vaccine and Anti-PD-1 Antibody in another window
Includes: Supplementary data